T38.7X2 Poisoning by androgens and anabolic congeners, intentional self-harm

Name of the Condition

• Poisoning by androgens and anabolic congeners, intentional self-harm

Summary

This condition describes intentional self-harm resulting from exposure to androgens or anabolic congeners. It includes toxic reactions or adverse effects from these substances when the exposure is deliberate, distinguishing it from accidental or therapeutic-related events. The code applies to cases where the intent is confirmed as self-harm.

Causes

Intentional self-harm involving androgens or anabolic agents may result from deliberate ingestion, injection, or other forms of exposure. These substances are often used therapeutically (e.g., for hormone replacement or anabolic effects) or misused, and self-harm can occur due to intentional overdose or misuse. Underlying factors like mental health conditions or substance use disorders may contribute to such incidents.

Risk Factors

• History of intentional self-harm or suicidal behavior
• Misuse or non-prescribed use of androgens/anabolic agents
• Access to androgens or anabolic substances
• Co-occurring mental health conditions (e.g., depression, anxiety)
• Substance use disorders involving hormonal agents

Symptoms

Symptoms depend on the specific agent and dose but may include virilization (e.g., hirsutism, voice deepening), electrolyte imbalances, hepatic dysfunction, or cardiovascular effects (e.g., hypertension, arrhythmias). Acute poisoning can cause nausea, vomiting, or organ toxicity, while chronic misuse may lead to long-term endocrine or metabolic disturbances.

Diagnosis

Diagnosis involves clinical evaluation of symptoms, history of exposure, and intent assessment. Laboratory tests (e.g., hormone levels, liver function, electrolytes) may help identify toxicity. Documentation of intentional self-harm, such as a suicide attempt or self-injurious behavior, is critical for coding. Differential diagnosis may include accidental poisoning or therapeutic adverse effects.

Treatment Options

Treatment focuses on stabilizing the patient, managing symptoms, and addressing the underlying intent. This may include decontamination (if appropriate), supportive care (e.g., fluid resuscitation, electrolyte correction), and monitoring for organ toxicity. Psychiatric evaluation and intervention are essential to address self-harm behaviors and prevent recurrence.

Prognosis and Follow-Up

Prognosis depends on the severity of poisoning, timely intervention, and underlying mental health status. Early treatment improves outcomes, but long-term complications (e.g., organ damage) may occur with severe exposure. Follow-up includes monitoring for recurrence, psychiatric care, and addressing any residual toxic effects.

Complications

Complications can include organ damage (e.g., hepatotoxicity, cardiovascular dysfunction), electrolyte imbalances, or chronic endocrine disorders. Severe cases may lead to life-threatening toxicity or long-term disability. Psychiatric complications, such as ongoing suicidal ideation, may also arise.

Lifestyle & Prevention

Prevention involves secure storage of androgens/anabolic agents, education on safe use, and addressing mental health concerns. Individuals at risk should have access to support services, and healthcare providers should screen for self-harm behaviors during prescribing or follow-up visits.

When to Seek Professional Help

Seek immediate medical attention if intentional self-harm with androgens/anabolic agents is suspected, especially with symptoms like severe nausea, vomiting, chest pain, or altered mental status. Prompt evaluation is critical to prevent life-threatening complications.

Tips for Medical Coders

Document the intent as "intentional self-harm" clearly in the medical record. Ensure the code T38.7X2 is used when the poisoning is confirmed as self-inflicted. Include details about the substance, route of exposure, and clinical findings to support coding accuracy. Differentiate from accidental or therapeutic adverse effects based on intent documentation.